Sign In
Buy CRSP
$52.08
+0.0600 (+0.115%)
At Close: Jun 03, 2026
Gene Editing Stocks: Why EDIT, NTLA, CRSP Stocks Are Climbing Today
03:34pm, Thursday, 05'th Aug 2021
Today, investors in gene editing stocks are seeing a lot of green as earnings were announced along with business updates from key players. The post Gene Editing Stocks: Why EDIT, NTLA, CRSP Stocks Are
Better Buy: Vertex vs. CRISPR
08:37am, Saturday, 31'st Jul 2021
Vertex might be undervalued, CRISPR Therapeutics might be overvalued, but both are looking for a home run.
CRSP Stock: The Good News Goosing CRISPR Therapeutics Shares Today
03:18pm, Friday, 30'th Jul 2021
Shares of CRSP stock are rising on Friday after CRISPR Therapeutics provided a positive business update regarding its leading drug candidate. The post CRSP Stock: The Good News Goosing CRISPR Therapeu
CRISPR Therapeutics (CRSP) Q2 Earnings Beat, Revenues Up Y/Y
12:10pm, Friday, 30'th Jul 2021
CRISPR Therapeutics' (CRSP) earnings and revenues beat estimates in the second quarter of 2021. Pipeline development in focus.
CRISPR Therapeutics AG (CRSP) Tops Q2 Earnings and Revenue Estimates
07:46pm, Thursday, 29'th Jul 2021
CRISPR Therapeutics AG (CRSP) delivered earnings and revenue surprises of 125.30% and 32.84%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2021 Financial Results
04:30pm, Thursday, 29'th Jul 2021
- More than 45 patients have been dosed with CTX001™ across CLIMB-Thal-111 and CLIMB-SCD-121 to date; completion of enrollment in both trials is expected in 2021-
Crispr Therapeutics Represents the Best of Emerging Biotechnology
06:00am, Monday, 26'th Jul 2021
CRSP stock may end up being a pioneer, or it may fizzle. The timeline until we know is typical of biotech stocks.
Is CRISPR Therapeutics a Millionaire-Maker Stock?
05:33am, Saturday, 24'th Jul 2021
It's already well on its way, but the road ahead will be long.
3 Things About CRISPR Therapeutics That Smart Investors Know
10:20am, Friday, 23'rd Jul 2021
The company is on track to be the first to market with a gene-editing therapy for blood disorders.
Crispr Therapeutics Has Bullish DNA
03:53pm, Thursday, 22'nd Jul 2021
Crispr Therapeutics isn't without risks, but that shouldn't dissuade investors from a CRSP stock collar purchase for core positioning. The post Crispr Therapeutics Has Bullish DNA appeared first on In
CRISPR Therapeutics AG (CRSP) to Report Q2 Results: Wall Street Expects Earnings Growth
04:48pm, Monday, 19'th Jul 2021
CRISPR Therapeutics AG (CRSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can CRISPR Therapeutics Stock Investors Steer Clear of Ethical Concerns?
06:00am, Monday, 19'th Jul 2021
While the technologies that undergird CRSP stock is nothing short of mind-blowing, you should be aware of the ethical risks. The post Can CRISPR Therapeutics Stock Investors Steer Clear of Ethical Con
CRISPR Therapeutics AG (CRSP) Stock Moves -0.67%: What You Should Know
07:14pm, Friday, 16'th Jul 2021
CRISPR Therapeutics AG (CRSP) closed at $126.25 in the latest trading session, marking a -0.67% move from the prior day.
Why CRISPR Therapeutics, Editas Medicine, and Beam Therapeutics Dropped This Week
11:02am, Friday, 16'th Jul 2021
After rallying on the coattails of Intelllia's breakthrough, these companies have given back their June gains.
The Top 3 Gene Editing Stocks to Own for the Next Decade
01:03pm, Monday, 12'th Jul 2021
Gene editing could revolutionize the way we treat diseases. Along the way, it could also create substantial opportunity for related stocks.
